Rinucumab (REGN 2176), a monoclonal antibody that acts as a PDGF inhibitor, holds potential for researching neovascular age-related macular degeneration [1].
CAS Number:
[1569263-06-4]
* VAT and and shipping costs not included. Errors and price changes excepted
